Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth:…
ALL INDIVIDUALS WHO PURCHASED OR ACQUIRED IMPACT THEORY FOUNDER’S KEYS BETWEEN OCTOBER 13, 2021, AND DECEMBER 6, 2021
COSTA MESA, Calif., Feb. 24, 2025 /PRNewswire/ -- The following statement is…
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a…